ConductScience.org, home

Paper39875017

Targeted gut microbiome therapy: Applications and prospects of probiotics, fecal microbiota transplantation and natural products in the management of type 2 diabetes.

Qin L and 6 others. Pharmacol Res, 2025. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Targeted gut microbiome therapy: Applications and prospects of probiotics, fecal microbiota transplantation and natural products in the management of type 2 diabetes. Papers, record 39875017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39875017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeted gut microbiome therapy: Applications and prospects of probiotics, fecal microbiota transplantation and natural products in the management of type 2 diabetes.
PubMed
Journal
Pharmacol Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
7.26, provisional
iCite
Revised in PubMed
2025-05-24
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qin LLuqi
2Fan BBei
3Zhou YYixia
4Zheng JJiahuan
5Diao RRao
6Wang FFengzhong
7Liu JJiameng

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Fecal Microbiota TransplantationMajor topic
Gastrointestinal MicrobiomeMajor topic
ProbioticsMajor topic
Biological ProductsMajor topic
Humans
Animals

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42942889Natural Products in Diabetes Mellitus: A Narrative Review of Mechanistic Insights into Metabolic Regulation and Therapeutic Potential.Nutrients2026https://conductscience.org/library/papers/42942889PubMed
42843354Fecal Microbiota Transplantation Beyond Clostridioides difficile Infection: Expanding Indications, Mechanisms, and Future Directions.J Korean Med Sci2026https://conductscience.org/library/papers/42843354PubMed
42652170Guanxinning Tablet Ameliorates Erectile Dysfunction in Diabetes Mellitus Rats with Involvement of PI3K/Akt/FOXO1 Signaling Pathway Modulation.Biomedicines2026https://conductscience.org/library/papers/42652170PubMed
41972561The Metabolic Calibration of Female Immune Plasticity: From X-Linked Vulnerability to Precision Metabotyping.Biology (Basel)2026https://conductscience.org/library/papers/41972561PubMed
41900387Role of Gut Microbiota in Bridging Vitamin D Deficiency and Type 2 Diabetes Mellitus Pathogenesis.Microorganisms2026https://conductscience.org/library/papers/41900387PubMed
41843084Modulating gut microbiota in type 2 diabetes mellitus: advances and challenges in precision medicine.Acta Diabetol2026https://conductscience.org/library/papers/41843084PubMed
41762381Gut Microbiota and Metabolic Health: From Dysbiosis to Therapeutics.Diabetes Ther2026https://conductscience.org/library/papers/41762381PubMed
417259981-Deoxynojirimycin with theaflavins ameliorates high-fat diet-induced insulin resistance in mice by modulating the gut microbiota.Front Nutr2025https://conductscience.org/library/papers/41725998PubMed
41710512Novel probiotic Lactobacillus helveticus WIS02 alleviates diabetes through multi-pronged regulation of glycolipid metabolism, pancreatic protection and gut microbiota remodeling.Front Microbiol2025https://conductscience.org/library/papers/41710512PubMed
41694562Targeting the gut microbiome for type 2 diabetes management: a scoping review of systematic reviews and meta-analyses.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41694562PubMed
41459531Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review.Front Immunol2025https://conductscience.org/library/papers/41459531PubMed
41457230Deciphering the association between dietary live microbe intake and metabolic syndrome: exploring the effects of inflammation and insulin resistance.J Health Popul Nutr2025https://conductscience.org/library/papers/41457230PubMed
41426511Glycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications.Food Sci Nutr2025https://conductscience.org/library/papers/41426511PubMed
41299966Xanthoceras sorbifolium Bunge Leaves Ameliorate Type 2 Diabetes Mellitus by Modulating Glucolipid Metabolism Through the Gut Microbiota-Metabolite Axis.Foods2025https://conductscience.org/library/papers/41299966PubMed
41158622Treatment of T2DM-related inflammation and vascular injury by regulating cellular crosstalk in the islet microenvironment.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41158622PubMed
41008596Elderberry-Based Multifunctional Prebiotic Systems Prepared via Spray Drying.Biomolecules2025https://conductscience.org/library/papers/41008596PubMed
40755760Novel insights into ORFV B2L DNA vaccine-mediated gut microbiota modulation and immune augmentation in rats.Front Immunol2025https://conductscience.org/library/papers/40755760PubMed
40729002Plant Heteropolysaccharides as Potential Anti-Diabetic Agents: A Review.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40729002PubMed
40574831The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches.Front Immunol2025https://conductscience.org/library/papers/40574831PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39875017

GET https://conductscience.org/api/papers/v1/39875017/authors